Stroke Biomarkers

  • Philip V. Peplow
  • Bridget Martinez
  • Svetlana A. Dambinova

Part of the Neuromethods book series (NM, volume 147)

Table of contents

  1. Front Matter
    Pages i-xvii
  2. Introduction

    1. Front Matter
      Pages 1-1
    2. Svetlana A. Dambinova, Bridget Martinez, Philip V. Peplow
      Pages 3-5
  3. Research Methods

    1. Front Matter
      Pages 7-7
    2. Daniel Arteaga, Bradford B. Worrall
      Pages 9-21
    3. Natalia Cullell, Jonathan González-Sánchez, Israel Fernández-Cadenas, Jerzy Krupinski
      Pages 23-34
    4. Philip V. Peplow, Bridget Martinez, D. Mascareñas, Svetlana A. Dambinova
      Pages 35-59
    5. Oiva Arvola, Anand Rao, Creed M. Stary
      Pages 61-78
    6. Deepti Vibha, Shubham Misra
      Pages 79-111
    7. Mark Slevin, Xenia Sawkulycz, Laura Combes, Baoqiang Guo, Wen-Hui Fang, Yasmin Zeinolabediny et al.
      Pages 113-122
  4. Translational Innovative Methods

    1. Front Matter
      Pages 123-123
    2. Alina González-Quevedo, Marisol Peña Sánchez, Sergio González García, María Caridad Menéndez Saínz, Marianela Arteche Prior
      Pages 125-155
    3. Edward C. Jauch, W. Frank Peacock IV, Judy Morgan, Jeff June, James Ireland
      Pages 157-169
    4. Galina A. Izykenova, German A. Khunteev, Ivan I. Krasnjuk, Vladimir L. Beloborodov, Svetlana A. Dambinova
      Pages 171-194
    5. Svetlana A. Dambinova, J. D. Mullins, J. D. Weissman, A. A. Potapov
      Pages 195-223
    6. G. V. Ponomarev, E. V. Alexandrova, Svetlana A. Dambinova, D. S. Asyutin, N. A. Konovalov, A. A. Skoromets
      Pages 225-243
  5. Clinical Methods

    1. Front Matter
      Pages 257-257
    2. J. D. Weissman, J. C. Boiser, C. Krebs, G. V. Ponomarev
      Pages 259-296
    3. Mathew Elameer, Christopher I. Price
      Pages 297-333
    4. Melvinder Basra, Robert E. Brightwell
      Pages 335-347
    5. V. A. Lukshin, D. Yu Usachev, A. V. Shmigelsky, A. A. Shulgina, A. A. Ogurtsova
      Pages 349-369
    6. Shrey Mathur, Klaus Fassbender
      Pages 371-395
  6. Conclusion

    1. Front Matter
      Pages 417-417
    2. Philip V. Peplow, Bridget Martinez, Svetlana A. Dambinova
      Pages 419-422
  7. Back Matter
    Pages 423-425

About this book


This volume presents the latest data on recent achievements in new and emerging technologies for stroke biomarkers and innovations in stroke assessment. The topics discussed in this book explore the role of upcoming biomarkers in different types of stroke, and explores techniques that will allow researchers to be more effective when approaching clinical management and patient care. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to ensure successful results in the laboratory.

Cutting-edge and comprehensive, Stroke Biomarkers is a valuable resource for both experimental and clinical scientists interested in expanding their knowledge in the field of stroke research.


S100β, glial fibrillary-associated protein cortical strokes antibodies ELISA deep sequencing quantum dots

Editors and affiliations

  • Philip V. Peplow
    • 1
  • Bridget Martinez
    • 2
  • Svetlana A. Dambinova
    • 3
  1. 1.Department of AnatomyUniversity of OtagoDunedinNew Zealand
  2. 2.Physical Chemistry and Applied Spectroscopy, Chemistry DivisionLos Alamos National LabLos AlamosUSA
  3. 3.Institute of Pharmacy, I.M. Sechenov First Moscow, State Medical University Moscow, RussiaBrain Biomarkers Research Lab, Emory Decatur Hospital, Emory HealthcareDecaturUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media, LLC, part of Springer Nature 2020
  • Publisher Name Humana, New York, NY
  • eBook Packages Springer Protocols
  • Print ISBN 978-1-4939-9681-0
  • Online ISBN 978-1-4939-9682-7
  • Series Print ISSN 0893-2336
  • Series Online ISSN 1940-6045
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Consumer Packaged Goods